IL6 and head and neck squamous cell carcinoma: Therefore, we hypothesized that targeting of IL-6 signaling could reverse the resistant phenotype in tumor cells, thereby enhancing the anti-tumor effects of cisplatin and radiation treatment in HNSCC.